Precision medicine service provides a data driven strategy in tailored treatment based on patients’ features derived from genomic data, medical records as well as habitual information.

Since its foundation in 2003, CbsBioscience has been dedicated to develop big data & AI based platform through continuous collaborative studies with national and international strong research institutes.
The innovative precision medicine platform technology enables one-stop genomic test to facilitate cancer treatment determination by providing comprehensive cancer treatment evidences.

Precision medicine service helps physicians select treatments (surgery or anti-cancer regimen) that are most likely to help patients based on a genetic understanding of their disease.

• Innovative, integrated, original technologies (10+ years R&D experiences, 5+ years of entrance barrier)
• Independently developed innovative platform technology that relates to 6 fields including big data and artificial Intelligence (commercialized product: 1, publications: 21, patents: 14 etc.)
• Over 10 years of accumulation in clinical & experimental data through multi-center collaborative research, the foundation of CBSBIO precision medicine, established high market entry barriers to competitors